Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ryan Miller

Showing results (61-70 of 112) with videos related to

Pageof 12
Sort By:
Plos One|July 6, 2018
PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibitionRobert S McNeill, Emily E Stroobant, Erin Smithberger, et al.
Plos One|May 8, 2013
Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancerCarey K Anders, Barbara Adamo, Olga Karginova, et al.
Brain Pathology (Zurich, Switzerland)|May 3, 2008
Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 casesArie Perry, C Ryan Miller, Meena Gujrati, et al.
Veterinary Pathology|July 1, 2021
Immunohistochemical evaluation of immune cell infiltration in canine gliomasGregory A Krane, Carly A O'Dea, David E Malarkey, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 11, 2024
Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancerPrachi Bajpai, Sumit Agarwal, Farrukh Afaq, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2013
Evolutionary etiology of high-grade astrocytomasYurong Song, Qian Zhang, Burak Kutlu, et al.
Neuro-Oncology|July 21, 2025
BRD2 Bromodomain-Mediated Regulation of Cell State Plasticity Modulates Therapy Response in GlioblastomaRaghavendra Vadla, Brett Taylor, Yohei Miyake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor modelsGina Song, David B Darr, Charlene M Santos, et al.
Cell Reports|July 29, 2022
Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancerZainab Shonibare, Mehri Monavarian, Kathleen O'Connell, et al.
The Journal of Clinical Investigation|January 18, 2014
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewalBing Zhou, Jeffrey S Damrauer, Sean T Bailey, et al.
Pageof 12

Showing results (61-70 of 112) with videos related to

Sort By:
Pageof 12
Plos One|July 6, 2018
PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibitionRobert S McNeill, Emily E Stroobant, Erin Smithberger, et al.
Plos One|May 8, 2013
Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancerCarey K Anders, Barbara Adamo, Olga Karginova, et al.
Brain Pathology (Zurich, Switzerland)|May 3, 2008
Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 casesArie Perry, C Ryan Miller, Meena Gujrati, et al.
Veterinary Pathology|July 1, 2021
Immunohistochemical evaluation of immune cell infiltration in canine gliomasGregory A Krane, Carly A O'Dea, David E Malarkey, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 11, 2024
Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancerPrachi Bajpai, Sumit Agarwal, Farrukh Afaq, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2013
Evolutionary etiology of high-grade astrocytomasYurong Song, Qian Zhang, Burak Kutlu, et al.
Neuro-Oncology|July 21, 2025
BRD2 Bromodomain-Mediated Regulation of Cell State Plasticity Modulates Therapy Response in GlioblastomaRaghavendra Vadla, Brett Taylor, Yohei Miyake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2014
Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor modelsGina Song, David B Darr, Charlene M Santos, et al.
Cell Reports|July 29, 2022
Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancerZainab Shonibare, Mehri Monavarian, Kathleen O'Connell, et al.
The Journal of Clinical Investigation|January 18, 2014
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewalBing Zhou, Jeffrey S Damrauer, Sean T Bailey, et al.
Pageof 12